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ABSTRACT
Multi-colour ﬂow cytometry was applied to deter-
mine T-cell-speciﬁc interferon-c, interleukin-2 and
tumour necrosis factor-a expression in children
with tuberculosis and non-tuberculosis mycobac-
terial lymphadenopathy (NTM-L). In vitro stimu-
lation of peripheral blood mononuclear cells with
puriﬁed protein derivative from Mycobacterium
tuberculosis (tuberculin) and M. avium (sensitin)
revealed differential recognition of tuberculin and
sensitin in both study groups. Ratios of tuberculin-
speciﬁc and sensitin-speciﬁc T-cell proportions in
individual patients discriminated between
children with tuberculosis or NTM-L. These ﬁnd-
ings have the potential to improve the differential
diagnosis of mycobacterial infections.
Keywords Childhood tuberculosis, ﬂow cytometry,
intracellular cytokine staining, non-tuberculosis myco-
bacterial, sensitin, tuberculin
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Lymphadenopathy in children can be caused by
M. tuberculosis or non-tuberculosis mycobacteria
(NTM) [1]. Rates of non-tuberculosis mycobacte-
rial lymphadenopathy (NTM-L) in children have
increased during recent years in industrialized
countries, whereas tuberculosis rates are decreas-
ing [2,3]. Differential diagnosis of tuberculosis and
NTM-L has major implications for the treatment
procedure but can only be accomplished by
bacterial culture lasting at least 3 weeks. Conse-
quently, presumptive diagnosis that relies on
clinical ﬁndings, patient anamnesis and tuberculin
skin test (TST) guides the treatment choice.
Different approaches have been evaluated to
improve the differential diagnosis of tuberculosis
and NTM-L. On the one hand, the TST induration
sizes induced by tuberculin have been analysed
[4,5]. These studies identiﬁed differences in the
mean induration size between NTM-infected and
M. tuberculosis-infected individuals. However,
high variances between individuals and the
marked overlap between the study groups ren-
dered induration sizes insufﬁcient as biomarkers,
especially in paediatric cases [4]. On the other
hand, concomitant TST analyses of tuberculin and
sensitin (dual skin testing) have been performed
[4,6]. Dual skin testing and calculation of the ratio
of responses against each antigen discriminated
between NTM and M. tuberculosis infection
in adults [6,7], whereas results from studies
in children were less convincing [8]. These
ambiguous results may be caused by cross-reac-
tivity against the antigens prevalent in both
tuberculin and sensitin preparations.
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Here we used ﬂow cytometry, a highly sensi-
tive and speciﬁc method, to determine speciﬁc
T-cell responses against puriﬁed protein deriva-
tive from M. tuberculosis (tuberculin) and puriﬁed
protein derivative from M. avium (sensitin) in
children with tuberculosis or NTM-L. Intracellu-
lar analyses of cytokines, namely interferon-c
(IFN-c), tumour necrosis factor-a (TNF-a), and
interleukin-2 (IL-2), were used as readouts after
short-term in vitro restimulation.
Peripheral blood (3 mL) was obtained from ten
children with culture-conﬁrmed tuberculosis and
nine children with culture-conﬁrmed NTM-L
recruited at the Department of Paediatric Pneu-
mology and Immunology, Charite´, in Berlin,
Germany. The patients’ characteristics are sum-
marized in Table 1. This study was approved by
the local ethics committee (EA 2 ⁄ 028 ⁄ 04).
Peripheral blood mononuclear cells (PBMCs)
were isolated by density centrifugation, (Biocoll;
Invitrogen, Carlsbad, CA, USA) following the
manufacturer’s instructions. PBMCs (2 ·
105 cells ⁄well) were then stimulated with tuber-
culin, sensitin (each 10 lg ⁄mL) (Statens Serum
Institute, Copenhagen, Denmark), or Staphylococ-
cus enterotoxin B (1 lg ⁄mL) (Sigma-Aldrich,
St. Louis, MI, USA), or were unstimulated for
20 h in 200 lL of RPMI (Gibco) containing 5%
human serum (Sigma) and 1% L-glutamine
(Sigma). During the ﬁnal 15 h, brefeldin A was
added to avoid release of cytokines from the
Golgi apparatus. Cells were then ﬁxed and per-
meabilized using BD Biosciences (New Jersey,
USA) cytoﬁx ⁄ cytoperm, following the manufac-
turer’s instructions, before monoclonal antibody
(mAb) mixtures were added. These mAb mix-
tures contained anti-IFN-c mAb (APC-labelled),
anti-IL-2 mAb (ﬂuorescein isothiocyanate-la-
belled), and anti-TNF-a mAb (Alexa 700-labelled)
(all BD Biosciences), combined with anti-CD4
mAb (APC-Cy7-labelled), anti-CD3 mAb (Paciﬁc
Blue-labelled), and anti-CD45RO mAb (PE-Cy7-
labelled). An LSRII ﬂow cytometer (BD Bioscienc-
es) was used for measurement, and FCS express
software (De Novo, Los Angeles, CA, USA) was
used for data analyses (see Fig. S1 for gating
procedures). The Mann–Whitney U-test was
used to determine signiﬁcant differences in
cytokine-expressing T-cell proportions between
study groups, and Student’s t-test was applied to
compare ratios of stimulation values. These tests
were selected on the basis of Kolmogorov–
Smirnov normality testing with Lilliefors’
correction.
CD4+ T-cells were the predominant cytokine-
producing T-cell population after antigen-speciﬁc
in vitro stimulation (data not shown). The pro-
portions of IFN-c-expressing, IL-2-expressing and
TNF-a-expressing T-cells after restimulation with
tuberculin in PBMCs from children with tubercu-
losis were only slightly higher than those in
PBMCs from children with NTM-L (Fig. 1a). For
sensitin, slightly higher IFN-c-expressing, IL-2-
expressing and TNF-a-expressing T-cell propor-
Table 1. Clinical characteristics of children with tuberculosis (A–I) and children with non-tuberculosis mycobacterial
lymphadenopathy (J–R)
Case Age Gender
TST*
(mm)
QuantiFERON – TB
Gold
T-SPOT
TB
Pathogen (from gastric
lavage, bronchoscopy,
or extirpated lymph nodes) Clinical features
A 5 years F 30 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
B 9 years M 30 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
C 4 years M 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
D 8 months F 8 Negative Negative M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
E 10 years F 30 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
F 14 years M 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
G 4 years F 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
H 5 years F 20 Positive Positive M. tuberculosis Multiresistant primary pulmonary tuberculosis;
culture-conﬁrmed
I 8 years F 20 Positive Positive M. tuberculosis Primary pulmonary tuberculosis; culture-conﬁrmed
J 8 years F 20 Negative Negative M. avium Lymphadenopathy; culture-conﬁrmed
K 2 years M 15 Negative Negative M. avium Lymphadenopathy; culture-conﬁrmed
L 5 years M 10 Negative Negative M. avium Lymphadenopathy; culture-conﬁrmed
M 3 years M 10 Negative Negative M. avium Lymphadenopathy; culture-conﬁrmed
N 5 years F 6 ND Negative M. avium Lymphadenopathy; culture-conﬁrmed
O 6 years M 10 Negative ND M. avium Lymphadenopathy; culture-conﬁrmed
P 2 years F 10 Negative Negative M. intracellulare Lymphadenopathy; culture-conﬁrmed
Q 2 years F 3 Negative Negative M. avium Lymphadenopathy; culture-conﬁrmed
R 3 years F 10 Negative Negative M. intracellulare Lymphadenopathy; culture-conﬁrmed
TST, tuberculin skin test; F, female; M, male; ND, not deﬁned.
*RT23, 2 TU (Statens Serum Institute, Copenhagen, Denmark).
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tions were detected in PBMCs of children with
NTM-L than in those of children with tuberculo-
sis (p <0.05; for all cytokines) (Fig. 1b). No differ-
ences were detected in the T-cell responses to the
superantigen Staphylococcus enterotoxin B
between the study groups (data not shown).
Owing to the strong variations in cytokine
responses of individual donors, the percentages
induced by tuberculin and sensitin overlapped
markedly between the study groups (Fig. 1a,b).
Therefore, comparison of IFN-c-secreting, IL-2-
secreting and TNF-a-secreting T-cell proportions
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Fig. 1. Proportions of interferon-c (IFN-c)-expressing, interleukin-2 (IL-2)-expressing and tumour necrosis factor-a (TNFa)-
expressing memory T-cells from children with tuberculosis (TB) and non-tuberculosis mycobacterial lymphadenopathy
(NTM-L). Multiple scattergraphs indicate IFN-c-expressing (left panel, squares), IL-2-expressing (middle panel, circles),
and TNF-a-expressing (right panel, triangle) (separated by dotted lines) T-cell proportions speciﬁc for (a) tuberculin and
(b) sensitin in peripheral blood mononuclear cells (PBMCs) from children with tuberculosis (dark grey symbols) and those
with NTM-L (bright grey symbols). (c, d) Comparisons of individual tuberculin-speciﬁc and sensitin-speciﬁc T-cell
proportions of children with tuberculosis (c) and NTM-L (d) are shown. Symbols from same patients are connected by
straight lines. Presentations are as described for (a) and (b). (e) Ratios (tuberculin ⁄ sensitin) of cytokine-secreting memory
T-cell proportions in PBMCs from individual patients are shown. Each symbol represents a ratio from an individual donor.
Normality testing was performed using Kolmogorov–Smirnov testing with Lilliefors’ correction. Accordingly, two-sided
p values for the Mann–Whitney U-test are indicated as *p <0.05) and **p <0.01) in (a–d), and Student’s t-test values as
***p <0.001) in (e).
Research Notes 1081
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 1065–1086
speciﬁc for tuberculin or sensitin was insufﬁcient
to discriminate between children with tuberculo-
sis and those with NTM-L.
Next, the CD4+ T-cell responses to tuberculin
and sensitin were determined for each individual
donor. Signiﬁcantly higher proportions of tuber-
culin-speciﬁc T-cells were detected in children
with tuberculosis (Fig. 1c) and signiﬁcantly higher
proportions of sensitin-speciﬁc T-cells in children
with NTM-L (Fig. 1d) (p <0.05; for all cytokines).
As the relative proportions of tuberculin-speciﬁc
and sensitin-speciﬁc T-cells correlated strongly in
individual patients (p <0.01 for all three cytokines
in both study groups, data not shown), cross-
reactivity against the antigens is likely, as has been
described by others [5].
Consequently, the ratios of cytokine-expressing
T-cell proportions induced by tuberculin and
sensitin were determined in individual patients
from both study groups. The individual cytokine
ratios revealed highly signiﬁcant differences
between the study groups for IFN-c (p <0.001),
IL-2 (p <0.001), and TNF-a (p <0.001) (Fig. 1e).
Notably, ratios of cytokine-expressing T-cell
proportions revealed non-overlapping results for
all cytokines between children with tuberculosis
and thosewithNTM-L (Fig. 1e). These resultswere
in accordance with studies comparing dual skin
testing with tuberculin and sensitin in adults, and
demonstrated for the ﬁrst time that the analysis of
T-cell responses against both mycobacterial pro-
tein preparations in parallel can contribute to
improved differential diagnosis in children [7].
In particular, the high speciﬁcity of ﬂow cyto-
metry-based analyses and the enrolment of
strictly stratiﬁed study groups (Table 1) may
account for the contradictory results obtained in
previous studies concerning dual skin testing
in children [8]. The present study suggests that
both sensitin and tuberculin preparations contain
exclusive immunogenic proteins. For M. tubercu-
losis, speciﬁc immunodominant proteins have
been identiﬁed and are already being used in
diagnostic tests [9,10]. These IFN-c release assays
have shown improved speciﬁcity and sensitivity
as compared to the TST, but are probably less
reliable if used for the diagnosis of immunocom-
promised patients [11]. Immunity based on
serological analyses against components speciﬁ-
cally expressed by M. avium has been analysed in
patients with tuberculosis as well as in those with
NTM-L [12,13], with promising results from a
very recent study in adults [13].
Our assay provides the possibility of detecting
T-cell immunity speciﬁc for M. avium infection.
This is a major difference from the IFN-c release
assays, which detect M. tuberculosis infection.
Therefore, we consider our ﬁnding to be an initial
step to characterize the inﬂuence of co-infection
with NTM on tuberculosis and other infectious
diseases (e.g. human immunodeﬁciency virus
(HIV)). Especially in regions with high incidences
of NTM infections, these co-infections are relevant
[14].
Furthermore, in immunocompromised donors
(e.g. HIV-infected), false-negative results of the
TST and of IFN-c release assays are prevalent, and
hence the number of truly M. tuberculosis-infected
individuals among these patients is underesti-
mated [11]. Ongoing studies will determine the
efﬁcacy of our assay in detecting mycobacterial
infections in this group of patients.
In conclusion, the combined analyses of cyto-
kine-expressing T-cell proportions speciﬁc for
tuberculin or sensitin in individual patients rather
then the response to one of these antigens
discriminated between children with tuberculosis
and those with NTM-L. All three cytokines, IFN-c,
TNF-a and IL-2, were equally suited for discrim-
ination. We consider our ﬁndings an initial step
to: (i) identify sensitin-speciﬁc components; (ii)
analyse the impact of NTM co-infections on other
infectious diseases (e.g. in patients with HIV
infection); and (iii) develop a fast and reliable
method for discrimination between children with
tuberculosis and those with NTM-L.
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ABSTRACT
The distribution of genes encoding different iron
acquisition systems in enteroaggregative Escheri-
chia coli (EAEC) from adults with irritable bowel
syndrome and from healthy controls was exam-
ined using a PCR assay. As many as 95.5% of
EAEC carried the chuA gene coding for a haem
receptor, and the majority of these strains also had
yersiniobactin-encoding genes. Apart from yersi-
niobactin, enterobactin was the siderophore most
frequently associated with EAEC among those
strains examined. Genes encoding aerobactin and
salmochelin siderophores were less frequent in
the group of EAEC.
Keywords Enteroaggregative Escherichia coli, haem
receptor, iron uptake systems, irritable bowel syn-
drome, yersiniobactin
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